Cash From Investing Activities - Epizyme Inc (F:EPE) - Alpha Spread
E

Epizyme Inc
F:EPE

Watchlist Manager
Epizyme Inc
F:EPE
Watchlist
Price: 559 EUR 3.33% Market Closed
Market Cap: 92.2B EUR
Have any thoughts about
Epizyme Inc?
Write Note

Epizyme Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Epizyme Inc
Cash from Investing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
E
Epizyme Inc
F:EPE
Cash from Investing Activities
$89.3m
CAGR 3-Years
N/A
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Investing Activities
-$11.9B
CAGR 3-Years
-71%
CAGR 5-Years
-53%
CAGR 10-Years
-19%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Investing Activities
-$3.5B
CAGR 3-Years
34%
CAGR 5-Years
-16%
CAGR 10-Years
-23%
Amgen Inc
NASDAQ:AMGN
Cash from Investing Activities
-$27.8B
CAGR 3-Years
-136%
CAGR 5-Years
N/A
CAGR 10-Years
-6%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Investing Activities
-$3.6B
CAGR 3-Years
-183%
CAGR 5-Years
-82%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Investing Activities
-$2.8B
CAGR 3-Years
-12%
CAGR 5-Years
-5%
CAGR 10-Years
-15%

See Also

What is Epizyme Inc's Cash from Investing Activities?
Cash from Investing Activities
89.3m USD

Based on the financial report for Jun 30, 2022, Epizyme Inc's Cash from Investing Activities amounts to 89.3m USD.

What is Epizyme Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-1%

Over the last year, the Cash from Investing Activities growth was 130%.

Back to Top